0 Bewertungen

ID

22408

Beschreibung

Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV; ODM derived from: https://clinicaltrials.gov/show/NCT00614965

Link

https://clinicaltrials.gov/show/NCT00614965

Stichworte

  1. 02.06.17 02.06.17 -
Hochgeladen am

2. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Non Small Cell Lung Cancer NCT00614965

    Eligibility Non Small Cell Lung Cancer NCT00614965

    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    histologically or cytologically confirmed nsclc
    Beschreibung

    nsclc

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0007131
    age 18 -75 years
    Beschreibung

    age

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    performance status (who) <2
    Beschreibung

    who performance status

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1298650
    patients progressing after first-line docetaxel/gemcitabine treatment
    Beschreibung

    disease progression after first-line docetaxel/gemcitabine treatment

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0242656
    UMLS CUI [1,2]
    C1708063
    UMLS CUI [1,3]
    C0796493
    adequate bone marrow (absolute neutrophil count >1000/mm3, platelet count >100000/mm3, hemoglobin > 9 gr/ mm3)
    Beschreibung

    ANC, platelet count, hemoglobin

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0948762
    UMLS CUI [2]
    C0032181
    UMLS CUI [3]
    C0518015
    adequate liver (bilirubin <1.5 times upper limit of normal), renal (creatinine clearance > 50mg/min) and cardiac (lvef >50%) function
    Beschreibung

    bilirubin, creatinine clearance, lvef

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0201913
    UMLS CUI [2]
    C0373595
    UMLS CUI [3]
    C0428772
    presence of measurable disease (according to resist criteria)
    Beschreibung

    measurable disease

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    informed consent
    Beschreibung

    informed consent

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    psychiatric illness or social situation that would preclude study compliance
    Beschreibung

    mental disorder, social situation, compliance

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0004936
    UMLS CUI [1,2]
    C0748872
    UMLS CUI [1,3]
    C1321605
    UMLS CUI [1,4]
    C0525058
    other concurrent uncontrolled illness.
    Beschreibung

    concurrent uncontrolled illness

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0009488
    UMLS CUI [1,2]
    C0205318
    other invasive malignancy within the past 5 years except nonmelanoma skin cancer
    Beschreibung

    prior malignancy, nonmelanoma skin cancer

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C2735088
    UMLS CUI [2]
    C3281209

    Ähnliche Modelle

    Eligibility Non Small Cell Lung Cancer NCT00614965

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    nsclc
    Item
    histologically or cytologically confirmed nsclc
    boolean
    C0007131 (UMLS CUI [1])
    age
    Item
    age 18 -75 years
    boolean
    C0001779 (UMLS CUI [1])
    who performance status
    Item
    performance status (who) <2
    boolean
    C1298650 (UMLS CUI [1])
    disease progression after first-line docetaxel/gemcitabine treatment
    Item
    patients progressing after first-line docetaxel/gemcitabine treatment
    boolean
    C0242656 (UMLS CUI [1,1])
    C1708063 (UMLS CUI [1,2])
    C0796493 (UMLS CUI [1,3])
    ANC, platelet count, hemoglobin
    Item
    adequate bone marrow (absolute neutrophil count >1000/mm3, platelet count >100000/mm3, hemoglobin > 9 gr/ mm3)
    boolean
    C0948762 (UMLS CUI [1])
    C0032181 (UMLS CUI [2])
    C0518015 (UMLS CUI [3])
    bilirubin, creatinine clearance, lvef
    Item
    adequate liver (bilirubin <1.5 times upper limit of normal), renal (creatinine clearance > 50mg/min) and cardiac (lvef >50%) function
    boolean
    C0201913 (UMLS CUI [1])
    C0373595 (UMLS CUI [2])
    C0428772 (UMLS CUI [3])
    measurable disease
    Item
    presence of measurable disease (according to resist criteria)
    boolean
    C1513041 (UMLS CUI [1])
    informed consent
    Item
    informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    mental disorder, social situation, compliance
    Item
    psychiatric illness or social situation that would preclude study compliance
    boolean
    C0004936 (UMLS CUI [1,1])
    C0748872 (UMLS CUI [1,2])
    C1321605 (UMLS CUI [1,3])
    C0525058 (UMLS CUI [1,4])
    concurrent uncontrolled illness
    Item
    other concurrent uncontrolled illness.
    boolean
    C0009488 (UMLS CUI [1,1])
    C0205318 (UMLS CUI [1,2])
    prior malignancy, nonmelanoma skin cancer
    Item
    other invasive malignancy within the past 5 years except nonmelanoma skin cancer
    boolean
    C2735088 (UMLS CUI [1])
    C3281209 (UMLS CUI [2])

    Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

    Mit * gekennzeichnete Felder sind notwendig.

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video